BWXT Selling Medical Business to Nordic Capital in Transaction Valued at up to $800 Million

BWXT entered into a definitive agreement to sell its medical business, including BWXT Medical and the Kinectrics medical isotopes unit, to Nordic Capital for up to $800 million. The company will retain a minority ownership stake in the divested business, allowing it to focus resources on its core nuclear national security and commercial nuclear power markets.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.